Ben-Shlomo, Y <br/><br/>
Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry.  [electronic resource] 

 -  BMJ (Clinical research ed.)  Apr 1998 
 - 1191-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0959-8138 
<br/><br/><label>Standard No.: </label>10.1136/bmj.316.7139.1191  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiparkinson Agents--adverse effects<br/>Bromocriptine--adverse effects<br/>Cause of Death<br/>Persons with Disabilities<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Levodopa--adverse effects<br/>Male<br/>Parkinson Disease--drug therapy<br/>Proportional Hazards Models<br/>Selegiline--adverse effects<br/>Survival Rate<br/>Treatment Failure